Fabrinet (NYSE:FN - Get Free Report) updated its fourth quarter 2025 earnings guidance on Monday. The company provided EPS guidance of 2.500-2.700 for the period, compared to the consensus EPS estimate of 2.650. The company issued revenue guidance of $860.0 million-$900.0 million, compared to the consensus revenue estimate of $885.8 million.
Analyst Upgrades and Downgrades
Several equities analysts have issued reports on the stock. JPMorgan Chase & Co. increased their price objective on shares of Fabrinet from $220.00 to $235.00 and gave the company a "neutral" rating in a report on Tuesday. Needham & Company LLC reissued a "buy" rating and set a $280.00 price target on shares of Fabrinet in a research report on Tuesday. Rosenblatt Securities increased their price objective on Fabrinet from $230.00 to $250.00 and gave the stock a "buy" rating in a research report on Tuesday. Barclays set a $234.00 price target on shares of Fabrinet and gave the company an "equal weight" rating in a research note on Tuesday. Finally, B. Riley raised shares of Fabrinet from a "sell" rating to a "neutral" rating and lowered their price objective for the company from $178.00 to $176.00 in a research note on Friday, April 4th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, Fabrinet presently has a consensus rating of "Hold" and an average price target of $239.29.
Get Our Latest Stock Analysis on FN
Fabrinet Trading Up 1.2 %
Shares of NYSE FN traded up $2.36 during mid-day trading on Wednesday, reaching $207.21. The company had a trading volume of 93,116 shares, compared to its average volume of 814,244. Fabrinet has a 52-week low of $148.55 and a 52-week high of $281.79. The stock has a market cap of $7.42 billion, a P/E ratio of 23.28 and a beta of 0.95. The firm has a 50 day simple moving average of $199.00 and a two-hundred day simple moving average of $220.77.
Fabrinet (NYSE:FN - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The technology company reported $2.52 EPS for the quarter, topping the consensus estimate of $2.47 by $0.05. The company had revenue of $871.80 million for the quarter, compared to analyst estimates of $857.12 million. Fabrinet had a return on equity of 18.48% and a net margin of 10.44%. The firm's revenue was up 19.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.39 earnings per share. On average, equities analysts expect that Fabrinet will post 9.4 EPS for the current year.
Fabrinet Company Profile
(
Get Free Report)
Fabrinet provides optical packaging and precision optical, electro-mechanical, and electronic manufacturing services in North America, the Asia-Pacific, and Europe. The company offers a range of advanced optical and electro-mechanical capabilities in the manufacturing process, including process design and engineering, supply chain management, manufacturing, printed circuit board assembly, advanced packaging, integration, final assembly, and testing.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Fabrinet, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fabrinet wasn't on the list.
While Fabrinet currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.